Request for Covid-19 Impact Assessment of this Report
The United States Core Needle Biopsy for Soft Tissue market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Core Needle Biopsy for Soft Tissue market, reaching US$ million by the year 2028. As for the Europe Core Needle Biopsy for Soft Tissue landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Core Needle Biopsy for Soft Tissue players cover BD, Medtronic, IZI Medical, and Medax, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Core Needle Biopsy for Soft Tissue market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Below 10 cm
10-15 cm
15-20 cm
Above 20 cm
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals & Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
BD
Medtronic
IZI Medical
Medax
ARGON MEDICAL
Ranfac
Merit Medical
INRAD
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Core Needle Biopsy for Soft Tissue Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Core Needle Biopsy for Soft Tissue by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Core Needle Biopsy for Soft Tissue by Country/Region, 2017, 2022 & 2028
2.2 Core Needle Biopsy for Soft Tissue Segment by Type
2.2.1 Below 10 cm
2.2.2 10-15 cm
2.2.3 15-20 cm
2.2.4 Above 20 cm
2.3 Core Needle Biopsy for Soft Tissue Sales by Type
2.3.1 Global Core Needle Biopsy for Soft Tissue Sales Market Share by Type (2017-2022)
2.3.2 Global Core Needle Biopsy for Soft Tissue Revenue and Market Share by Type (2017-2022)
2.3.3 Global Core Needle Biopsy for Soft Tissue Sale Price by Type (2017-2022)
2.4 Core Needle Biopsy for Soft Tissue Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Core Needle Biopsy for Soft Tissue Sales by Application
2.5.1 Global Core Needle Biopsy for Soft Tissue Sale Market Share by Application (2017-2022)
2.5.2 Global Core Needle Biopsy for Soft Tissue Revenue and Market Share by Application (2017-2022)
2.5.3 Global Core Needle Biopsy for Soft Tissue Sale Price by Application (2017-2022)
3 Global Core Needle Biopsy for Soft Tissue by Company
3.1 Global Core Needle Biopsy for Soft Tissue Breakdown Data by Company
3.1.1 Global Core Needle Biopsy for Soft Tissue Annual Sales by Company (2020-2022)
3.1.2 Global Core Needle Biopsy for Soft Tissue Sales Market Share by Company (2020-2022)
3.2 Global Core Needle Biopsy for Soft Tissue Annual Revenue by Company (2020-2022)
3.2.1 Global Core Needle Biopsy for Soft Tissue Revenue by Company (2020-2022)
3.2.2 Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Company (2020-2022)
3.3 Global Core Needle Biopsy for Soft Tissue Sale Price by Company
3.4 Key Manufacturers Core Needle Biopsy for Soft Tissue Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Core Needle Biopsy for Soft Tissue Product Location Distribution
3.4.2 Players Core Needle Biopsy for Soft Tissue Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Core Needle Biopsy for Soft Tissue by Geographic Region
4.1 World Historic Core Needle Biopsy for Soft Tissue Market Size by Geographic Region (2017-2022)
4.1.1 Global Core Needle Biopsy for Soft Tissue Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Core Needle Biopsy for Soft Tissue Annual Revenue by Geographic Region
4.2 World Historic Core Needle Biopsy for Soft Tissue Market Size by Country/Region (2017-2022)
4.2.1 Global Core Needle Biopsy for Soft Tissue Annual Sales by Country/Region (2017-2022)
4.2.2 Global Core Needle Biopsy for Soft Tissue Annual Revenue by Country/Region
4.3 Americas Core Needle Biopsy for Soft Tissue Sales Growth
4.4 APAC Core Needle Biopsy for Soft Tissue Sales Growth
4.5 Europe Core Needle Biopsy for Soft Tissue Sales Growth
4.6 Middle East & Africa Core Needle Biopsy for Soft Tissue Sales Growth
5 Americas
5.1 Americas Core Needle Biopsy for Soft Tissue Sales by Country
5.1.1 Americas Core Needle Biopsy for Soft Tissue Sales by Country (2017-2022)
5.1.2 Americas Core Needle Biopsy for Soft Tissue Revenue by Country (2017-2022)
5.2 Americas Core Needle Biopsy for Soft Tissue Sales by Type
5.3 Americas Core Needle Biopsy for Soft Tissue Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Core Needle Biopsy for Soft Tissue Sales by Region
6.1.1 APAC Core Needle Biopsy for Soft Tissue Sales by Region (2017-2022)
6.1.2 APAC Core Needle Biopsy for Soft Tissue Revenue by Region (2017-2022)
6.2 APAC Core Needle Biopsy for Soft Tissue Sales by Type
6.3 APAC Core Needle Biopsy for Soft Tissue Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Core Needle Biopsy for Soft Tissue by Country
7.1.1 Europe Core Needle Biopsy for Soft Tissue Sales by Country (2017-2022)
7.1.2 Europe Core Needle Biopsy for Soft Tissue Revenue by Country (2017-2022)
7.2 Europe Core Needle Biopsy for Soft Tissue Sales by Type
7.3 Europe Core Needle Biopsy for Soft Tissue Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Core Needle Biopsy for Soft Tissue by Country
8.1.1 Middle East & Africa Core Needle Biopsy for Soft Tissue Sales by Country (2017-2022)
8.1.2 Middle East & Africa Core Needle Biopsy for Soft Tissue Revenue by Country (2017-2022)
8.2 Middle East & Africa Core Needle Biopsy for Soft Tissue Sales by Type
8.3 Middle East & Africa Core Needle Biopsy for Soft Tissue Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Core Needle Biopsy for Soft Tissue
10.3 Manufacturing Process Analysis of Core Needle Biopsy for Soft Tissue
10.4 Industry Chain Structure of Core Needle Biopsy for Soft Tissue
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Core Needle Biopsy for Soft Tissue Distributors
11.3 Core Needle Biopsy for Soft Tissue Customer
12 World Forecast Review for Core Needle Biopsy for Soft Tissue by Geographic Region
12.1 Global Core Needle Biopsy for Soft Tissue Market Size Forecast by Region
12.1.1 Global Core Needle Biopsy for Soft Tissue Forecast by Region (2023-2028)
12.1.2 Global Core Needle Biopsy for Soft Tissue Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Core Needle Biopsy for Soft Tissue Forecast by Type
12.7 Global Core Needle Biopsy for Soft Tissue Forecast by Application
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Core Needle Biopsy for Soft Tissue Product Offered
13.1.3 BD Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Core Needle Biopsy for Soft Tissue Product Offered
13.2.3 Medtronic Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 IZI Medical
13.3.1 IZI Medical Company Information
13.3.2 IZI Medical Core Needle Biopsy for Soft Tissue Product Offered
13.3.3 IZI Medical Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 IZI Medical Main Business Overview
13.3.5 IZI Medical Latest Developments
13.4 Medax
13.4.1 Medax Company Information
13.4.2 Medax Core Needle Biopsy for Soft Tissue Product Offered
13.4.3 Medax Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Medax Main Business Overview
13.4.5 Medax Latest Developments
13.5 ARGON MEDICAL
13.5.1 ARGON MEDICAL Company Information
13.5.2 ARGON MEDICAL Core Needle Biopsy for Soft Tissue Product Offered
13.5.3 ARGON MEDICAL Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 ARGON MEDICAL Main Business Overview
13.5.5 ARGON MEDICAL Latest Developments
13.6 Ranfac
13.6.1 Ranfac Company Information
13.6.2 Ranfac Core Needle Biopsy for Soft Tissue Product Offered
13.6.3 Ranfac Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ranfac Main Business Overview
13.6.5 Ranfac Latest Developments
13.7 Merit Medical
13.7.1 Merit Medical Company Information
13.7.2 Merit Medical Core Needle Biopsy for Soft Tissue Product Offered
13.7.3 Merit Medical Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merit Medical Main Business Overview
13.7.5 Merit Medical Latest Developments
13.8 INRAD
13.8.1 INRAD Company Information
13.8.2 INRAD Core Needle Biopsy for Soft Tissue Product Offered
13.8.3 INRAD Core Needle Biopsy for Soft Tissue Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 INRAD Main Business Overview
13.8.5 INRAD Latest Developments
14 Research Findings and Conclusion
Table 1. Core Needle Biopsy for Soft Tissue Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Core Needle Biopsy for Soft Tissue Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Below 10 cm
Table 4. Major Players of 10-15 cm
Table 5. Major Players of 15-20 cm
Table 6. Major Players of Above 20 cm
Table 7. Global Core Needle Biopsy for Soft Tissue Sales by Type (2017-2022) & (K Units)
Table 8. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Type (2017-2022)
Table 9. Global Core Needle Biopsy for Soft Tissue Revenue by Type (2017-2022) & ($ million)
Table 10. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Type (2017-2022)
Table 11. Global Core Needle Biopsy for Soft Tissue Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Core Needle Biopsy for Soft Tissue Sales by Application (2017-2022) & (K Units)
Table 13. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Application (2017-2022)
Table 14. Global Core Needle Biopsy for Soft Tissue Revenue by Application (2017-2022)
Table 15. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Application (2017-2022)
Table 16. Global Core Needle Biopsy for Soft Tissue Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Core Needle Biopsy for Soft Tissue Sales by Company (2020-2022) & (K Units)
Table 18. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Company (2020-2022)
Table 19. Global Core Needle Biopsy for Soft Tissue Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Company (2020-2022)
Table 21. Global Core Needle Biopsy for Soft Tissue Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Core Needle Biopsy for Soft Tissue Producing Area Distribution and Sales Area
Table 23. Players Core Needle Biopsy for Soft Tissue Products Offered
Table 24. Core Needle Biopsy for Soft Tissue Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Core Needle Biopsy for Soft Tissue Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Core Needle Biopsy for Soft Tissue Sales Market Share Geographic Region (2017-2022)
Table 29. Global Core Needle Biopsy for Soft Tissue Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Core Needle Biopsy for Soft Tissue Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Country/Region (2017-2022)
Table 33. Global Core Needle Biopsy for Soft Tissue Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Core Needle Biopsy for Soft Tissue Sales by Country (2017-2022) & (K Units)
Table 36. Americas Core Needle Biopsy for Soft Tissue Sales Market Share by Country (2017-2022)
Table 37. Americas Core Needle Biopsy for Soft Tissue Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Core Needle Biopsy for Soft Tissue Revenue Market Share by Country (2017-2022)
Table 39. Americas Core Needle Biopsy for Soft Tissue Sales by Type (2017-2022) & (K Units)
Table 40. Americas Core Needle Biopsy for Soft Tissue Sales Market Share by Type (2017-2022)
Table 41. Americas Core Needle Biopsy for Soft Tissue Sales by Application (2017-2022) & (K Units)
Table 42. Americas Core Needle Biopsy for Soft Tissue Sales Market Share by Application (2017-2022)
Table 43. APAC Core Needle Biopsy for Soft Tissue Sales by Region (2017-2022) & (K Units)
Table 44. APAC Core Needle Biopsy for Soft Tissue Sales Market Share by Region (2017-2022)
Table 45. APAC Core Needle Biopsy for Soft Tissue Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Core Needle Biopsy for Soft Tissue Revenue Market Share by Region (2017-2022)
Table 47. APAC Core Needle Biopsy for Soft Tissue Sales by Type (2017-2022) & (K Units)
Table 48. APAC Core Needle Biopsy for Soft Tissue Sales Market Share by Type (2017-2022)
Table 49. APAC Core Needle Biopsy for Soft Tissue Sales by Application (2017-2022) & (K Units)
Table 50. APAC Core Needle Biopsy for Soft Tissue Sales Market Share by Application (2017-2022)
Table 51. Europe Core Needle Biopsy for Soft Tissue Sales by Country (2017-2022) & (K Units)
Table 52. Europe Core Needle Biopsy for Soft Tissue Sales Market Share by Country (2017-2022)
Table 53. Europe Core Needle Biopsy for Soft Tissue Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Core Needle Biopsy for Soft Tissue Revenue Market Share by Country (2017-2022)
Table 55. Europe Core Needle Biopsy for Soft Tissue Sales by Type (2017-2022) & (K Units)
Table 56. Europe Core Needle Biopsy for Soft Tissue Sales Market Share by Type (2017-2022)
Table 57. Europe Core Needle Biopsy for Soft Tissue Sales by Application (2017-2022) & (K Units)
Table 58. Europe Core Needle Biopsy for Soft Tissue Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Core Needle Biopsy for Soft Tissue Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Core Needle Biopsy for Soft Tissue Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Core Needle Biopsy for Soft Tissue
Table 68. Key Market Challenges & Risks of Core Needle Biopsy for Soft Tissue
Table 69. Key Industry Trends of Core Needle Biopsy for Soft Tissue
Table 70. Core Needle Biopsy for Soft Tissue Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Core Needle Biopsy for Soft Tissue Distributors List
Table 73. Core Needle Biopsy for Soft Tissue Customer List
Table 74. Global Core Needle Biopsy for Soft Tissue Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Core Needle Biopsy for Soft Tissue Sales Market Forecast by Region
Table 76. Global Core Needle Biopsy for Soft Tissue Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Core Needle Biopsy for Soft Tissue Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Core Needle Biopsy for Soft Tissue Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Core Needle Biopsy for Soft Tissue Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Core Needle Biopsy for Soft Tissue Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Core Needle Biopsy for Soft Tissue Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Core Needle Biopsy for Soft Tissue Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Core Needle Biopsy for Soft Tissue Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Core Needle Biopsy for Soft Tissue Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Core Needle Biopsy for Soft Tissue Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Core Needle Biopsy for Soft Tissue Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Core Needle Biopsy for Soft Tissue Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Core Needle Biopsy for Soft Tissue Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Core Needle Biopsy for Soft Tissue Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Core Needle Biopsy for Soft Tissue Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Core Needle Biopsy for Soft Tissue Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Core Needle Biopsy for Soft Tissue Revenue Market Share Forecast by Application (2023-2028)
Table 94. BD Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 95. BD Core Needle Biopsy for Soft Tissue Product Offered
Table 96. BD Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. BD Main Business
Table 98. BD Latest Developments
Table 99. Medtronic Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 100. Medtronic Core Needle Biopsy for Soft Tissue Product Offered
Table 101. Medtronic Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Medtronic Main Business
Table 103. Medtronic Latest Developments
Table 104. IZI Medical Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 105. IZI Medical Core Needle Biopsy for Soft Tissue Product Offered
Table 106. IZI Medical Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. IZI Medical Main Business
Table 108. IZI Medical Latest Developments
Table 109. Medax Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 110. Medax Core Needle Biopsy for Soft Tissue Product Offered
Table 111. Medax Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Medax Main Business
Table 113. Medax Latest Developments
Table 114. ARGON MEDICAL Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 115. ARGON MEDICAL Core Needle Biopsy for Soft Tissue Product Offered
Table 116. ARGON MEDICAL Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. ARGON MEDICAL Main Business
Table 118. ARGON MEDICAL Latest Developments
Table 119. Ranfac Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 120. Ranfac Core Needle Biopsy for Soft Tissue Product Offered
Table 121. Ranfac Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Ranfac Main Business
Table 123. Ranfac Latest Developments
Table 124. Merit Medical Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 125. Merit Medical Core Needle Biopsy for Soft Tissue Product Offered
Table 126. Merit Medical Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Merit Medical Main Business
Table 128. Merit Medical Latest Developments
Table 129. INRAD Basic Information, Core Needle Biopsy for Soft Tissue Manufacturing Base, Sales Area and Its Competitors
Table 130. INRAD Core Needle Biopsy for Soft Tissue Product Offered
Table 131. INRAD Core Needle Biopsy for Soft Tissue Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. INRAD Main Business
Table 133. INRAD Latest Developments
List of Figures
Figure 1. Picture of Core Needle Biopsy for Soft Tissue
Figure 2. Core Needle Biopsy for Soft Tissue Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Core Needle Biopsy for Soft Tissue Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Core Needle Biopsy for Soft Tissue Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Core Needle Biopsy for Soft Tissue Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Below 10 cm
Figure 10. Product Picture of 10-15 cm
Figure 11. Product Picture of 15-20 cm
Figure 12. Product Picture of Above 20 cm
Figure 13. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Type in 2021
Figure 14. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Type (2017-2022)
Figure 15. Core Needle Biopsy for Soft Tissue Consumed in Hospitals & Clinics
Figure 16. Global Core Needle Biopsy for Soft Tissue Market: Hospitals & Clinics (2017-2022) & (K Units)
Figure 17. Core Needle Biopsy for Soft Tissue Consumed in Ambulatory Surgical Centers
Figure 18. Global Core Needle Biopsy for Soft Tissue Market: Ambulatory Surgical Centers (2017-2022) & (K Units)
Figure 19. Core Needle Biopsy for Soft Tissue Consumed in Others
Figure 20. Global Core Needle Biopsy for Soft Tissue Market: Others (2017-2022) & (K Units)
Figure 21. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Application (2017-2022)
Figure 22. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Application in 2021
Figure 23. Core Needle Biopsy for Soft Tissue Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Company in 2021
Figure 25. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Geographic Region in 2021
Figure 27. Global Core Needle Biopsy for Soft Tissue Sales Market Share by Region (2017-2022)
Figure 28. Global Core Needle Biopsy for Soft Tissue Revenue Market Share by Country/Region in 2021
Figure 29. Americas Core Needle Biopsy for Soft Tissue Sales 2017-2022 (K Units)
Figure 30. Americas Core Needle Biopsy for Soft Tissue Revenue 2017-2022 ($ Millions)
Figure 31. APAC Core Needle Biopsy for Soft Tissue Sales 2017-2022 (K Units)
Figure 32. APAC Core Needle Biopsy for Soft Tissue Revenue 2017-2022 ($ Millions)
Figure 33. Europe Core Needle Biopsy for Soft Tissue Sales 2017-2022 (K Units)
Figure 34. Europe Core Needle Biopsy for Soft Tissue Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Core Needle Biopsy for Soft Tissue Revenue 2017-2022 ($ Millions)
Figure 37. Americas Core Needle Biopsy for Soft Tissue Sales Market Share by Country in 2021
Figure 38. Americas Core Needle Biopsy for Soft Tissue Revenue Market Share by Country in 2021
Figure 39. United States Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Core Needle Biopsy for Soft Tissue Sales Market Share by Region in 2021
Figure 44. APAC Core Needle Biopsy for Soft Tissue Revenue Market Share by Regions in 2021
Figure 45. China Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Core Needle Biopsy for Soft Tissue Sales Market Share by Country in 2021
Figure 52. Europe Core Needle Biopsy for Soft Tissue Revenue Market Share by Country in 2021
Figure 53. Germany Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Core Needle Biopsy for Soft Tissue Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Core Needle Biopsy for Soft Tissue Revenue Market Share by Country in 2021
Figure 60. Egypt Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Core Needle Biopsy for Soft Tissue Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Core Needle Biopsy for Soft Tissue in 2021
Figure 66. Manufacturing Process Analysis of Core Needle Biopsy for Soft Tissue
Figure 67. Industry Chain Structure of Core Needle Biopsy for Soft Tissue
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...